RemeGen Co., Ltd. (HKG:9995)
76.25
-8.75 (-10.29%)
Jul 17, 2026, 4:08 PM HKT
RemeGen Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, RemeGen stock has a consensus rating of "Buy" and an average price target of $115.48. The average 1-year stock price forecast is 51.45% higher than the current stock price, while the lowest is $76.43 (+0.24%) and the highest is $143.46 (+88.14%).
Price Target: $115.48 (+51.45%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 9, 2026.
Analyst Ratings
The average analyst rating for RemeGen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 9 | 8 | 8 |
| Buy | 4 | 4 | 4 | 4 | 3 | 2 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $129.00 | Buy | Maintains | $129.00 | +69.18% | Jun 9, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $141.10 | Buy | Maintains | $141.10 | +85.05% | Jun 8, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains $98.00 | Hold | Maintains | $98.00 | +28.52% | May 28, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $125.00 | Buy | Maintains | $125.00 | +63.93% | May 15, 2026 |
Unknown Analyst First Shanghai Securities No rating | First Shanghai Securities | Buy Maintains $137.20 | Buy | Maintains | $137.20 | +79.93% | May 13, 2026 |
Financial Forecast
Revenue This Year
7.05B
from 3.25B
Increased by 116.97%
Revenue Next Year
4.72B
from 7.05B
Decreased by -33.08%
EPS This Year
6.85
from 1.29
Increased by 430.84%
EPS Next Year
1.68
from 6.85
Decreased by -75.49%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.